Showing results (131-140 of 200) with videos related to
Sort By:
Pageof 20
Anti-Cancer Drugs|December 13, 1997
The ex vivo chemosensitivity profile of choroidal melanomaN Myatt, I A Cree, C M Kurbacher, et al.Critical Reviews in Clinical Laboratory Sciences|April 11, 2017
Using circulating cell-free DNA to monitor personalized cancer therapyMichael Oellerich, Ekkehard Schütz, Julia Beck, et al.Ophthalmology|July 1, 1997
Multidisciplinary management of refractory orbital rhabdomyosarcomaG E Mannor, G E Rose, P N Plowman, et al.The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Linear growth and final height after treatment for Cushing's disease in childhoodM C Lebrethon, A B Grossman, F Afshar, et al.Ophthalmology|January 27, 1998
Treatment of retinoblastoma vitreous base seedingS A Madreperla, J L Hungerford, D Doughty, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|June 19, 2015
Enhanced γ-H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometryChristopher N Parris, Sheba Adam Zahir, Hussein Al-Ali, et al.The British Journal of Ophthalmology|January 1, 1993
Relationship of regression pattern to recurrence in retinoblastomaA D Singh, D Garway-Heath, S Love, et al.Journal of Cancer|December 1, 2017
The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1<sup>+/-</sup> lymphoblastoid cellsEmma C Bourton, Pia-Amata Ahorner, Piers N Plowman, et al.Journal of Neurosurgery|January 10, 2002
A multidisciplinary team approach to skull base chordomasH A Crockard, T Steel, N Plowman, et al.Journal of Steroid Biochemistry|November 1, 1985
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancerR I Nicholson, K J Walker, A Turkes, et al.Pageof 20